Some employers are choosing to focus on alternative weight management strategies instead of covering GLP-1s
Materials and Methods These prespecified exploratory analyses examined changes from baseline in Appetite Visual Analogue Scale (VAS) and Eating Inventory (EI) scores after 24 and 36 weeks of onceweekly treatment with placebo, dulaglutide 1.5 mg, or retatrutide 0.5, 4, 8, or 12 mg in 275 adults with T2D
Underlying Conditions: All peptides and drugs that influence growth hormone should be avoided by individuals with active cancer, due to their potential for tumor growth stimulation
What Happens if Semaglutide is Not Stored Properly
What the insurance industry doesn't expect is for you to do something about it
Before anyone considers GLP-1 therapy at any dose let me be clear about who needs to avoid these medications: Personal or family history of medullary thyroid cancer or MEN-2 syndrome contraindicated History of pancreatitis may not be safe Severe gastroparesis these drugs will worsen it Pregnancy or active conception planning not recommended These are real medications with real side effects: nausea, vomiting, constipation, gallbladder problems